Alexandrina Vodenitcharova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Alexandrina Vodenitcharova has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Antoniya Yanakieva
Department of Health Technology Assessment, Faculty of Public Health, Medical University, 1527 Sofia, Bulgaria
3 shared publications A. Lamprianidou
Faculty of Pharmacy , Medical University – Sofia , Bulgaria
1 shared publicationAnd
1 shared publicationB. Bayram
Department of Neuroscience, Imaging and Clinical Sciences , “G. d’Annunzio” University of Chieti-Pescara – Chieti , Italy
1 shared publicationB. Vasileva
1 Faculty of Public Health Medical University, Sofia, Bulgaria
1 shared publication- Borislav Borissov
Department of Health Technology Assessment, Faculty of Public Health, Medical University, Sofia, Bulgaria, Bulgaria
1 shared publication
Latest Publications
- Open Access
- 4 March 2026
- Published by MDPI AG in Epidemiologia
- Vol. 7 (2) , 39
Trends in Tuberculosis Incidence and Mortality in South Africa and Bulgaria (2000–2023): The Impact of Income, Poverty, Unemployment, and Universal Health Coverage
Background: Tuberculosis (TB) remains a major global public health challenge, with substantial variation across countries. South Africa has one of the highest TB incidence and mortality rates globally, while Bulgaria, a low-incidence country, faces a persistent TB burden among vulnerable populations. Objectives: To compare national trends in TB incidence and mortality in South Africa and Bulgaria from 2000 to 2023 and explore associations with selected socioeconomic indicators and health system coverage. Methods: An ecological, descriptive, analytical study used national-level data from the WHO, World Bank, and official statistics. TB trends were analyzed alongside income, poverty, unemployment, and Universal Health Coverage indicators. Time series measures and Pearson correlation were used descriptively to summarize co-variation over time. Results: Between 2000 and 2023, TB incidence declined by approximately 44% in the Republic of South Africa and 69% in Bulgaria. In both countries, TB incidence co-varied strongly with unemployment (RSA: r = 0.805; BG: r = 0.723). In Bulgaria, TB incidence was also strongly negatively associated with GDP per capita (r = −0.910), whereas no significant association with GDP was observed in South Africa. These findings indicate that TB trends co-varied more closely with labour market conditions in both contexts, while broader economic growth co-occurred with declining TB incidence only in Bulgaria. Conclusions: TB trends co-occurred with changes in socioeconomic conditions and health system coverage, with differing patterns across contexts. Findings highlight the relevance of equity-oriented, context-specific TB control strategies integrated with social and economic policies.
- 4 March 2026
- Published by MDPI AG in Epidemiologia
- Vol. 7 (2) , 39
Open AccessTrends in Tuberculosis Incidence and Mortality in South Africa and Bulgaria (2000–2023): The Impact of Income, Poverty, Unemployment, and Universal Health Coverage
Background: Tuberculosis (TB) remains a major global public health challenge, with substantial variation across countries. South Africa has one of the highest TB incidence and mortality rates globally, while Bulgaria, a low-incidence country, faces a persistent TB burden among vulnerable populations. Objectives: To compare national trends in TB incidence and mortality in South Africa and Bulgaria from 2000 to 2023 and explore associations with selected socioeconomic indicators and health system coverage. Methods: An ecological, descriptive, analytical study used national-level data from the WHO, World Bank, and official statistics. TB trends were analyzed alongside income, poverty, unemployment, and Universal Health Coverage indicators. Time series measures and Pearson correlation were used descriptively to summarize co-variation over time. Results: Between 2000 and 2023, TB incidence declined by approximately 44% in the Republic of South Africa and 69% in Bulgaria. In both countries, TB incidence co-varied strongly with unemployment (RSA: r = 0.805; BG: r = 0.723). In Bulgaria, TB incidence was also strongly negatively associated with GDP per capita (r = −0.910), whereas no significant association with GDP was observed in South Africa. These findings indicate that TB trends co-varied more closely with labour market conditions in both contexts, while broader economic growth co-occurred with declining TB incidence only in Bulgaria. Conclusions: TB trends co-occurred with changes in socioeconomic conditions and health system coverage, with differing patterns across contexts. Findings highlight the relevance of equity-oriented, context-specific TB control strategies integrated with social and economic policies.
- Open Access
- 1 March 2026
- Published by Walter de Gruyter GmbH in Acta Medica Bulgarica
- Vol. 53 (1) , 93-97
Artificial Intelligence in Healthcare: Advancing Innovation and Ethics to Foster Well-Being
Artificial intelligence (AI) is reshaping healthcare by enhancing diagnostic precision, treatment personalization, and overall patient care. By leveraging technologies such as machine learning, deep learning, natural language processing, and computer vision, AI enables faster and more accurate decision-making, supports drug discovery and development, and facilitates remote patient monitoring. Beyond improving clinical outcomes, AI also contributes to holistic well-being by addressing physical, mental, social, occupational, and environmental health. Wearable AI devices promote proactive health management, virtual assistants improve mental health accessibility, and predictive analytics enable early intervention for disease prevention. However, the integration of AI in healthcare presents challenges, including data privacy concerns, algorithmic bias, and the need for transparency and trust. Ensuring the responsible and equitable deployment of AI requires robust ethical guidelines, interdisciplinary collaboration, and policies that safeguard patient rights while maximizing the technology’s benefits. By exploring both the transformative potential and inherent challenges of AI, this paper aims to highlight the critical role of AI in shaping the future of healthcare and human well-being.
- 1 March 2026
- Published by Walter de Gruyter GmbH in Acta Medica Bulgarica
- Vol. 53 (1) , 93-97
Open AccessArtificial Intelligence in Healthcare: Advancing Innovation and Ethics to Foster Well-Being
Artificial intelligence (AI) is reshaping healthcare by enhancing diagnostic precision, treatment personalization, and overall patient care. By leveraging technologies such as machine learning, deep learning, natural language processing, and computer vision, AI enables faster and more accurate decision-making, supports drug discovery and development, and facilitates remote patient monitoring. Beyond improving clinical outcomes, AI also contributes to holistic well-being by addressing physical, mental, social, occupational, and environmental health. Wearable AI devices promote proactive health management, virtual assistants improve mental health accessibility, and predictive analytics enable early intervention for disease prevention. However, the integration of AI in healthcare presents challenges, including data privacy concerns, algorithmic bias, and the need for transparency and trust. Ensuring the responsible and equitable deployment of AI requires robust ethical guidelines, interdisciplinary collaboration, and policies that safeguard patient rights while maximizing the technology’s benefits. By exploring both the transformative potential and inherent challenges of AI, this paper aims to highlight the critical role of AI in shaping the future of healthcare and human well-being.
- Open Access
- 27 February 2026
- Published by Pensoft Publishers in Pharmacia
- Vol. 73, 1-4
Professional responsibility of the pharmacist in chronic pharmacotherapy: Ethical and economic perspectives
Chronic pharmacotherapy poses significant challenges for contemporary pharmaceutical practice due to its long-term nature and dependence on sustained patient engagement. Medication non-adherence remains a major cause of suboptimal therapeutic outcomes and increased health care costs, highlighting the growing importance of pharmaceutical care. This article presents a narrative and conceptual review of the professional responsibility of the pharmacist in chronic pharmacotherapy, focusing on medication adherence as a key ethical and economic dimension of pharmaceutical practice. Professional responsibility is conceptualised as a longitudinal and shared process embedded in routine pharmaceutical care, extending beyond regulatory compliance. The analysis also addresses the impact of digital health technologies on pharmaceutical practice, emphasising the continuing role of professional judgement and accountability. The article affirms the pharmacist’s position as a key professional actor in long-term medication management and health system sustainability.
- 27 February 2026
- Published by Pensoft Publishers in Pharmacia
- Vol. 73, 1-4
Open AccessProfessional responsibility of the pharmacist in chronic pharmacotherapy: Ethical and economic perspectives
Chronic pharmacotherapy poses significant challenges for contemporary pharmaceutical practice due to its long-term nature and dependence on sustained patient engagement. Medication non-adherence remains a major cause of suboptimal therapeutic outcomes and increased health care costs, highlighting the growing importance of pharmaceutical care. This article presents a narrative and conceptual review of the professional responsibility of the pharmacist in chronic pharmacotherapy, focusing on medication adherence as a key ethical and economic dimension of pharmaceutical practice. Professional responsibility is conceptualised as a longitudinal and shared process embedded in routine pharmaceutical care, extending beyond regulatory compliance. The analysis also addresses the impact of digital health technologies on pharmaceutical practice, emphasising the continuing role of professional judgement and accountability. The article affirms the pharmacist’s position as a key professional actor in long-term medication management and health system sustainability.
- Open Access
- 19 December 2025
- Published by Pensoft Publishers in Pharmacia
- Vol. 72, 1-6
Economic effects of non-pharmacological interventions in low back pain
Low back pain (LBP) is a global health issue with enormous socioeconomic impact. It ranks first in terms of disability and is the leading cause of years lived with disability (YLDs) worldwide. The aim of this analysis is to present an overview of non-pharmacological methods for treating low back pain and to assess their potential to prevent or reduce the need for pharmacological and surgical treatment. This 10-year literature review confirms that several non-pharmacological interventions, particularly psychosocial and exercise-based approaches, are cost-effective alternatives for the treatment of low back pain. Continued research on innovative treatment delivery methods, combined with improved methodology, is essential for obtaining information on economic costs, informing health policies, and optimizing care for patients with LBP.
- 19 December 2025
- Published by Pensoft Publishers in Pharmacia
- Vol. 72, 1-6
Open AccessEconomic effects of non-pharmacological interventions in low back pain
Low back pain (LBP) is a global health issue with enormous socioeconomic impact. It ranks first in terms of disability and is the leading cause of years lived with disability (YLDs) worldwide. The aim of this analysis is to present an overview of non-pharmacological methods for treating low back pain and to assess their potential to prevent or reduce the need for pharmacological and surgical treatment. This 10-year literature review confirms that several non-pharmacological interventions, particularly psychosocial and exercise-based approaches, are cost-effective alternatives for the treatment of low back pain. Continued research on innovative treatment delivery methods, combined with improved methodology, is essential for obtaining information on economic costs, informing health policies, and optimizing care for patients with LBP.
- Open Access
- 27 November 2025
- Published by Pensoft Publishers in Pharmacia
- Vol. 72, 1-4
The dual economic impact of COVID-19 vaccine hesitancy - Bulgaria’s conundrum case
Bulgaria is assumed to be the country with the lowest COVID-19 vaccination coverage in the EU. The present study aims to highlight the economic impact of vaccine hesitancy. The period analyzed is from 1 January 2021 to 31 December 2021, examining hospitalization costs for COVID-19 patients, vaccine application costs, and vaccine type and dose administered. Results demonstrate a net impact of BGN 97 686 089 (€49 946 104) if 30% of the eligible population had been vaccinated and BGN 146 529 133 (€74 919 156) if a 45% rate had been achieved. In addition, 5.1 million unused doses were scrapped—more than those administered. The public health impact of vaccine hesitancy in Bulgaria led to a preventable medical crisis, substantial economic losses due to avoidable hospitalizations, and significant additional costs associated with the destruction of unused vaccines.
- 27 November 2025
- Published by Pensoft Publishers in Pharmacia
- Vol. 72, 1-4
Open AccessThe dual economic impact of COVID-19 vaccine hesitancy - Bulgaria’s conundrum case
Bulgaria is assumed to be the country with the lowest COVID-19 vaccination coverage in the EU. The present study aims to highlight the economic impact of vaccine hesitancy. The period analyzed is from 1 January 2021 to 31 December 2021, examining hospitalization costs for COVID-19 patients, vaccine application costs, and vaccine type and dose administered. Results demonstrate a net impact of BGN 97 686 089 (€49 946 104) if 30% of the eligible population had been vaccinated and BGN 146 529 133 (€74 919 156) if a 45% rate had been achieved. In addition, 5.1 million unused doses were scrapped—more than those administered. The public health impact of vaccine hesitancy in Bulgaria led to a preventable medical crisis, substantial economic losses due to avoidable hospitalizations, and significant additional costs associated with the destruction of unused vaccines.
- Open Access
- 25 December 2024
- Published by MDPI AG in Healthcare
- Vol. 13 (1) , 19
Unity in Diversity and Diversity in Unity—Vaccination Policies in EU Countries
Background/Objectives: This article emphasizes the comprehensive importance of vaccination, exploring its role in disease prevention, addressing growing concerns around vaccine hesitancy, and underscoring the crucial need for high vaccination coverage rates. Methods: Our review examines EU-level and national policies on vaccination, utilizing EU sources, with a specific focus on regulatory and policy documents. Vaccination calendars in the EU were reviewed through the ECDC Vaccine Scheduler webpage. The parameters of this literature review were further selected in collaboration with an Emory Health sciences librarian using the following search terms: healthcare providers, communication, public health, informed consent, and bioethics. Results: The analysis of limited articles on community engagement, moral and political philosophy, and public health ethics informs the ethical consideration of informed consent in public health interventions. Countries exhibit varying relationships between their vaccination programs and society, with technocratic and populist influences shaping vaccination policies. Conclusions: Europe demonstrates diversity in vaccination policies, with availability, funding, and scheduling reflecting distinct approaches to vaccination.
- 25 December 2024
- Published by MDPI AG in Healthcare
- Vol. 13 (1) , 19
Open AccessUnity in Diversity and Diversity in Unity—Vaccination Policies in EU Countries
Background/Objectives: This article emphasizes the comprehensive importance of vaccination, exploring its role in disease prevention, addressing growing concerns around vaccine hesitancy, and underscoring the crucial need for high vaccination coverage rates. Methods: Our review examines EU-level and national policies on vaccination, utilizing EU sources, with a specific focus on regulatory and policy documents. Vaccination calendars in the EU were reviewed through the ECDC Vaccine Scheduler webpage. The parameters of this literature review were further selected in collaboration with an Emory Health sciences librarian using the following search terms: healthcare providers, communication, public health, informed consent, and bioethics. Results: The analysis of limited articles on community engagement, moral and political philosophy, and public health ethics informs the ethical consideration of informed consent in public health interventions. Countries exhibit varying relationships between their vaccination programs and society, with technocratic and populist influences shaping vaccination policies. Conclusions: Europe demonstrates diversity in vaccination policies, with availability, funding, and scheduling reflecting distinct approaches to vaccination.
- Open Access
- 1 May 2020
- Published by Walter de Gruyter GmbH in Acta Medica Bulgarica
- Vol. 47 (1) , 73-75
The Fundamental Significance of The Social and Ethical Criteria for Primary Care Quality Assessment
A vital aspect of the medical activity on which the medical care quality directly depends has been the doctor-patient relationship; it is of complex nature and is formed by a number of factors: professional ethics, communication culture of the doctor, the patients’ confidence in the doctor, etc. From an ethical point of view, the confidence of the patient has been an ethical indicator and criterion of particular importance for the quality and interpersonal relationship between the doctor and the patient. Data from the overview of a number of papers, as well as data from our own empirical study, has indicated the presence of a number of unresolved problems in this relationship. That has raised the significant necessity of a more thorough and comprehensive training of the medical staffin professional medical ethics in undergraduate and postgraduate training.
- 1 May 2020
- Published by Walter de Gruyter GmbH in Acta Medica Bulgarica
- Vol. 47 (1) , 73-75
Open AccessThe Fundamental Significance of The Social and Ethical Criteria for Primary Care Quality Assessment
A vital aspect of the medical activity on which the medical care quality directly depends has been the doctor-patient relationship; it is of complex nature and is formed by a number of factors: professional ethics, communication culture of the doctor, the patients’ confidence in the doctor, etc. From an ethical point of view, the confidence of the patient has been an ethical indicator and criterion of particular importance for the quality and interpersonal relationship between the doctor and the patient. Data from the overview of a number of papers, as well as data from our own empirical study, has indicated the presence of a number of unresolved problems in this relationship. That has raised the significant necessity of a more thorough and comprehensive training of the medical staffin professional medical ethics in undergraduate and postgraduate training.
- Open Access
- 6 February 2018
- Published by Peytchinski Publishing Ltd. in Journal of IMAB – Annual Proceeding (Scientific Papers)
- Vol. 25 (1) , 2362-2368
IMPLEMENTING OF EDUCATION IN BIOETHICS AT CONTEMPORARY SCHOOLS – FACTOR FOR HEALTHY LIFESTYLE OF THE GROWING UP GENERATION
- 6 February 2018
- Published by Peytchinski Publishing Ltd. in Journal of IMAB – Annual Proceeding (Scientific Papers)
- Vol. 25 (1) , 2362-2368
Open AccessIMPLEMENTING OF EDUCATION IN BIOETHICS AT CONTEMPORARY SCHOOLS – FACTOR FOR HEALTHY LIFESTYLE OF THE GROWING UP GENERATION